SSY GROUP (02005): Pibedil has been approved by the National Medical Products Administration (NMPA) for registration as an active pharmaceutical ingredient for use in marketed formulations.

24/02/2025

GMT Eight

SSY GROUP (02005) announced that the group's Pibedil has been approved by the China National Medical Products Administration as a raw material for use in marketed formulations, making it the third domestic company to receive approval. Pibedil is mainly used for the treatment of Parkinson's disease and circulatory disorders.

CanSino Biologics Inc. (688185.SH): DTcP-Hib-MCV4 combination vaccine clinical trial application approved.

CONSUN PHARMA (01681): Lee Cheuk Kwong appointed as Independent Non-executive Director.

Contact: contact@gmteight.com

SSY GROUP (02005): Pibedil has been approved by the National Medical Products Administration (NMPA) for registration as an active pharmaceutical ingredient for use in marketed formulations.

RECOMMEND

CH ENV ENERGY (00986) has been appointed as the sales agent for Sichuan Du Fu Wine Industry and will be renamed "Du Fu Wine Industry Group."

YAN TAT GROUP (01480) plans to acquire a property in Malaysia for 43.75 million Ringgit.

Sicc Co., Ltd. (688234.SH) has submitted an application to the Hong Kong Stock Exchange for the issuance and listing of overseas listed foreign capital stocks (H shares) and has published the application materials.